Dideoxy: Firstly the patents: You will see from your Google search for "uscom patents" that there are a string of patents and other IP that are often inter-related and cover the UCM technology. You will also note the extended time (some years) it takes to get the various patents approved and registered.
From what I can see the patents from the 1A forward have been well managed and still have the majority of a 20 year protection period to run.
The patent protection is a very broad Moat around the company as the core of it has taken some 16+ years to finalize registration.
From the USCOM Annual Report 2020: "Uscom holds approximately 20 patents and continue to grow IP with 2 powerful new patent applications in the last 12 months,including a new method of measuring and monitoring hypertension to accompany our BP+, and a patent to protect ourVENTITEST ventilator testing technology."
This IP and the investment security it underlines, has not yet been factored into the market price - it will happen and when it does I suspect the move up will be quite sudden and permanent.
USCOM Succession plan: [The following is all on the public record]. Rob Phillips has chosen to be the public face of the company and it is in truth his "baby" - He does seem to be everywhere, but what makes this possible, is a very well organised supporting structure that generates the Companies money. The structure is planned and perennial - at this time:
Rob Phillips, is Executive Director, Chairman, Chief Executive Officer.
Nick Schicht, General Manager has been there in a key role for at least 16 + years.
Directors range in experience from 17 years to recently appointed.
There is a 7 member Medical & Technology Advisory Board in place to duplicate and expand on Robs specialist medical knowledge
There is a head office in Sydney housing the consolidated entity.
Uscom Ltd. has five: 100% owned subsidiaries: Uscom Inc USA, Uscom Medical Ltd UK. Uscom Kft Hungry Europe, Beijing Uscom Consulting Co. LTD. China, and Uscom SNG Pte. Ltd. Singapore. Each of these subsidiaries has a certain degree of autonomy and some have special tasks within the overall organisation.
It is very clear that while Rob would be sorely missed - he has already put the steps in place that ensure Uscom Ltd survival.
Has this addressed your concerns?
- Forums
- ASX - By Stock
- Ann: Uscom 4E Annual Results 2020
UCM
uscom limited
Add to My Watchlist
0.00%
!
1.9¢

Dideoxy: Firstly the patents: You will see from your Google...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 46000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 0.014 |
1 | 132270 | 0.012 |
1 | 100000 | 0.010 |
1 | 150000 | 0.008 |
2 | 2000000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 46000 | 1 |
0.020 | 63256 | 1 |
0.021 | 24866 | 1 |
0.022 | 6549 | 1 |
0.055 | 95083 | 2 |
Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online